The multifaceted role of long non-coding RNA DLEU1 in cancer progression: implications for diagnosis and therapy

INTRODUCTION AND PURPOSE: Long non-coding RNAs are key regulators of gene expression and tumorigenesis. Deleted in leukemia 1 (DLEU1) is significant in cancer development. This article reviews DLEU1's role across cancers, assessing its diagnostic and therapeutic potential. METHODS: A review of scientific articles from PubMed and Google Scholar was conducted. DESCRIPTION OF THE STATE OF KNOWLEDGE: DLEU1 drives tumor growth in glioblastoma, esophageal, colorectal, and oral cancers by interacting with key miRNAs and genes, promoting malignancy. In breast and ovarian cancers, DLEU1 modulates migration and invasion via specific pathways. In cervical cancer, DLEU1 is linked to immune modulation and serves as a prognostic marker. SUMMARY: DLEU1 is a vital regulator in various cancers, offering potential as a diagnostic and therapeutic target.

Authors

Institutions

Publication Details

Journal
Quality in Sport
Published
2024-09-21
DOI
https://doi.org/10.12775/qs.2024.22.54285
Citations
1
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The multifaceted role of long non-coding RNA DLEU1 in cancer progression: implications for diagnosis and therapy

Natalia Żak, Julita Szarpak, Paweł Stanicki, Natalia Kusak et al.
1 citations
Quality in Sport
Cancer-related molecular mechanisms research
0.29
article

The multifaceted role of long non-coding RNA DLEU1 in cancer progression: implications for diagnosis and therapy

Natalia Żak, Julita Szarpak, Paweł Stanicki, Natalia Kusak, Aldona Pażyra, Barbara Jaworska
article en
1 citations

Abstract

INTRODUCTION AND PURPOSE: Long non-coding RNAs are key regulators of gene expression and tumorigenesis. Deleted in leukemia 1 (DLEU1) is significant in cancer development. This article reviews DLEU1's role across cancers, assessing its diagnostic and therapeutic potential. METHODS: A review of scientific articles from PubMed and Google Scholar was conducted. DESCRIPTION OF THE STATE OF KNOWLEDGE: DLEU1 drives tumor growth in glioblastoma, esophageal, colorectal, and oral cancers by interacting with key miRNAs and genes, promoting malignancy. In breast and ovarian cancers, DLEU1 modulates migration and invasion via specific pathways. In cervical cancer, DLEU1 is linked to immune modulation and serves as a prognostic marker. SUMMARY: DLEU1 is a vital regulator in various cancers, offering potential as a diagnostic and therapeutic target.

Quality in SportVol. 22
1 Military Clinical Hospital with Outpatient Clinic (PL), Wojewódzki Szpital Zespolony (PL), Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lubartowie (PL)
Good health and well-being
Openalex Percentile: Top 39%
Cancer-related molecular mechanisms research
0.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.